{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:07:56Z","timestamp":1791173276465,"version":"4.1.0"},"reference-count":41,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5,1]]},"abstract":"<jats:p>Background. With the widespread implementation of intrapartum antibiotic prophylaxis (IAP), the rate of early-onset neonatal sepsis and meningitis caused by Streptococcus agalactiae (group B streptococcus [GBS]) has decreased dramatically, especially in term infants. However, cases of GBS disease continue to occur despite IAP and incur significant morbidity and mortality. Inaccurate screening results, improper implementation of IAP, or antibiotic failure all may contribute to persistent disease.<\/jats:p>\n               <jats:p>Objective. To determine if clinical, procedural, or microbiologic factors influenced persistent early-onset GBS disease (EOGBS) cases in a single large maternity service after the institution of a screening-based protocol for IAP.<\/jats:p>\n               <jats:p>Methods. Retrospective review of all cases of culture-proven EOGBS at the Brigham and Women's Hospital (Boston, MA) from 1997 to 2003. Serotyping and surface protein analyses were performed on available disease isolates.<\/jats:p>\n               <jats:p>Results. A total of 67260 infants were live-born during this period. Twenty-five cases of EOGBS (0.37 of 1000 live births) were identified. The overall incidence of EOGBS progressively decreased with different approaches to IAP. Of the 25 cases identified after institution of a screening-based protocol, 17 (68%) occurred in term infants (1 death), and 8 (32%) occurred in preterm infants (3 deaths). Among the mothers of term infants, 14 of 17 (82%) had been screened GBS negative; 1 was GBS unknown. More than half of the mothers of term infants who had screened GBS negative (8 of 14) had intrapartum risk factors for neonatal infection but did not receive antibiotics before delivery. Ten of the 17 term infants were evaluated for infection because of clinical signs of illness, and the remainder were evaluated because of intrapartum sepsis risk factors. Of the mothers of preterm infants, by the time of delivery 3 of 8 had been documented as GBS positive, 2 of 8 had been documented GBS negative, and 3 of 8 remained unknown. Only 1 of 25 women received adequate IAP, but the isolate was resistant to the administered antibiotic (clindamycin). Antibiotic resistance was not a factor in any other case, and no dominant serovariant was identified among tested isolates. Procedural errors (lack of recognition of documented GBS colonization or failure to evaluate infants at risk for sepsis) were identified in 4 cases.<\/jats:p>\n               <jats:p>Conclusions. The majority of the remaining cases of EOGBS occurred in infants whose mothers screened negative for GBS colonization. Even in the setting of a maternal GBS-screening program, efforts to evaluate and treat infants with intrapartum clinical risk factors for early-onset sepsis remain important. Until effective vaccines against GBS are available for clinical use, development and implementation of rapid and sensitive techniques for screening for GBS status and antibiotic susceptibility at presentation may help prevent additional cases of invasive GBS disease.<\/jats:p>","DOI":"10.1542\/peds.2004-2275","type":"journal-article","created":{"date-parts":[[2005,5,2]],"date-time":"2005-05-02T19:38:07Z","timestamp":1115062687000},"page":"1240-1246","source":"Crossref","is-referenced-by-count":222,"title":["Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening"],"prefix":"10.1542","volume":"115","author":[{"given":"Karen M.","family":"Puopolo","sequence":"first","affiliation":[{"name":"Department of Newborn Medicine"},{"name":"Channing Laboratory"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C.","family":"Madoff","sequence":"additional","affiliation":[{"name":"Channing Laboratory"},{"name":"Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Eichenwald","sequence":"additional","affiliation":[{"name":"Department of Newborn Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2005,5,1]]},"reference":[{"key":"2021120819295198400_R1","doi-asserted-by":"crossref","unstructured":"McCracken GH Jr. Group B streptococcus: the new challenge in neonatal infections. J Pediatr.\u20081973;82:703\u2013706","DOI":"10.1016\/S0022-3476(73)80603-1"},{"key":"2021120819295198400_R2","unstructured":"Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective [published correction appears in MMWR Morb Mortal Wkly Rep. 1996;45:679]. MMWR Recomm Rep.\u20081996;45(RR-7):1\u201324"},{"key":"2021120819295198400_R3","doi-asserted-by":"crossref","unstructured":"Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. J Infect Dis.\u20081983;148:810\u2013816","DOI":"10.1093\/infdis\/148.5.810"},{"key":"2021120819295198400_R4","doi-asserted-by":"crossref","unstructured":"Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med.\u20081986;314:1665\u20131669","DOI":"10.1056\/NEJM198606263142603"},{"key":"2021120819295198400_R5","doi-asserted-by":"crossref","unstructured":"Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med.\u20082002;347:233\u2013239","DOI":"10.1056\/NEJMoa020205"},{"key":"2021120819295198400_R6","unstructured":"Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep.\u20082002;51(RR-11):1\u201322"},{"key":"2021120819295198400_R7","unstructured":"Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ.\u20081992;41(6):25\u201332"},{"key":"2021120819295198400_R8","unstructured":"Centers for Disease Control and Prevention. Diminishing racial disparities in early-onset neonatal group B streptococcal disease\u2014United States, 2000\u20132003. MMWR Morb Mortal Wkly Rep.\u20082004;53:502\u2013505"},{"key":"2021120819295198400_R9","doi-asserted-by":"crossref","unstructured":"Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med.\u20082000;342:15\u201320","DOI":"10.1056\/NEJM200001063420103"},{"key":"2021120819295198400_R10","doi-asserted-by":"crossref","unstructured":"Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics.\u20082001;108:1094\u20131098","DOI":"10.1542\/peds.108.5.1094"},{"key":"2021120819295198400_R11","doi-asserted-by":"crossref","unstructured":"Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics.\u20082002;110:690\u2013695","DOI":"10.1542\/peds.110.4.690"},{"key":"2021120819295198400_R12","doi-asserted-by":"crossref","unstructured":"Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of Gram-negative neonatal sepsis. Infect Dis Obstet Gynecol.\u20081999;7:210\u2013213","DOI":"10.1002\/(SICI)1098-0997(1999)7:4<210::AID-IDOG10>3.0.CO;2-8"},{"key":"2021120819295198400_R13","doi-asserted-by":"crossref","unstructured":"Chen KT, Tuomala RE, Cohen AP, Eichenwald EC, Lieberman E. No increase in rates of early-onset neonatal sepsis by non-group B streptococcus or ampicillin-resistant organisms. Am J Obstet Gynecol.\u20082001;185:854\u2013858","DOI":"10.1067\/mob.2001.117354"},{"key":"2021120819295198400_R14","doi-asserted-by":"crossref","unstructured":"Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med.\u20082002;347:240\u2013247","DOI":"10.1056\/NEJMoa012657"},{"key":"2021120819295198400_R15","doi-asserted-by":"crossref","unstructured":"Rentz AC, Samore MH, Stoddard GJ, Faix RG, Byington CL. Risk factors associated with ampicillin-resistant infection in newborns in the era of group B streptococcal prophylaxis. Arch Pediatr Adolesc Med.\u20082004;158:556\u2013560","DOI":"10.1001\/archpedi.158.6.556"},{"key":"2021120819295198400_R16","doi-asserted-by":"crossref","unstructured":"Alarcon A, Pena P, Salas S, Sancha M, Omenaca F. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis J.\u20082004;23:295\u2013299","DOI":"10.1097\/00006454-200404000-00004"},{"key":"2021120819295198400_R17","doi-asserted-by":"crossref","unstructured":"Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol.\u20082003;101:74\u201379","DOI":"10.1097\/00006250-200301000-00017"},{"key":"2021120819295198400_R18","doi-asserted-by":"crossref","unstructured":"Lin FY, Azimi PH, Weisman LE, et al. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995\u20131998. Clin Infect Dis.\u20082000;31:76\u201379","DOI":"10.1086\/313936"},{"key":"2021120819295198400_R19","doi-asserted-by":"crossref","unstructured":"Paoletti LJ, Bradford J, Paoletti LC. A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts. J Clin Microbiol.\u20081999;37:3759\u20133760","DOI":"10.1128\/JCM.37.11.3759-3760.1999"},{"key":"2021120819295198400_R20","unstructured":"Cloherty JC, Stark AR, eds. Manual of Neonatal Care. 4th ed. Philadelphia, PA: Lippincott-Raven; 1998:286\u2013287"},{"key":"2021120819295198400_R21","doi-asserted-by":"crossref","unstructured":"Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr.\u20081979;95:89\u201398","DOI":"10.1016\/S0022-3476(79)80096-7"},{"key":"2021120819295198400_R22","doi-asserted-by":"crossref","unstructured":"Escobar GJ, Li DK, Armstrong MA, et al. Neonatal sepsis workups in infants \u22652000 grams at birth: a population-based study. Pediatrics.\u20082000;106:256\u2013263","DOI":"10.1542\/peds.106.2.256"},{"key":"2021120819295198400_R23","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst.\u20081959;22:719\u2013748"},{"key":"2021120819295198400_R24","doi-asserted-by":"crossref","unstructured":"Pinto NM, Soskolne EI, Pearlman MD, Faix RG. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems. J Perinatol.\u20082003;23:265\u2013271","DOI":"10.1038\/sj.jp.7210899"},{"key":"2021120819295198400_R25","doi-asserted-by":"crossref","unstructured":"Velaphi S, Siegel JD, Wendel GD Jr, Cushion N, Eid WM, Sanchez PJ. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics.\u20082003;111:541\u2013547","DOI":"10.1542\/peds.111.3.541"},{"key":"2021120819295198400_R26","doi-asserted-by":"crossref","unstructured":"Baker CJ, Clark DJ, Barrett FF. Selective broth medium for isolation of group B streptococci. Appl Microbiol.\u20081973;26:884\u2013885","DOI":"10.1128\/am.26.6.884-885.1973"},{"key":"2021120819295198400_R27","doi-asserted-by":"crossref","unstructured":"Badri MS, Zawaneh S, Cruz AC, et al. Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis.\u20081977;135:308\u2013312","DOI":"10.1093\/infdis\/135.2.308"},{"key":"2021120819295198400_R28","doi-asserted-by":"crossref","unstructured":"Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. J Infect Dis.\u20081983;148:802\u2013809","DOI":"10.1093\/infdis\/148.5.802"},{"key":"2021120819295198400_R29","unstructured":"Quinlan JD, Hill DA, Maxwell BD, Boone S, Hoover F, Lense JJ. The necessity of both anorectal and vaginal cultures for group B streptococcus screening during pregnancy. J Fam Pract.\u20082000;49:447\u2013448"},{"key":"2021120819295198400_R30","doi-asserted-by":"crossref","unstructured":"Teese N, Henessey D, Pearce C, Kelly N, Garland S. Screening protocols for group B streptococcus: are transport media appropriate?Infect Dis Obstet Gynecol.\u20082003;11:199\u2013202","DOI":"10.1080\/10647440300025521"},{"key":"2021120819295198400_R31","doi-asserted-by":"crossref","unstructured":"Ostroff RM, Steaffens JW. Effect of specimen storage, antibiotics, and feminine hygiene products on the detection of group B streptococcus by culture and the STREP B OIA test. Diagn Microbiol Infect Dis.\u20081995;22:253\u2013259","DOI":"10.1016\/0732-8893(95)00046-D"},{"key":"2021120819295198400_R32","doi-asserted-by":"crossref","unstructured":"Meyn LA, Moore DM, Hillier SL, Krohn MA. Association of sexual activity with colonization and vaginal acquisition of group B streptococcus in nonpregnant women. Am J Epidemiol.\u20082002;155:949\u2013957","DOI":"10.1093\/aje\/155.10.949"},{"key":"2021120819295198400_R33","doi-asserted-by":"crossref","unstructured":"Anthony BF, Okada DM, Hobel CJ. Epidemiology of group B streptococcus: longitudinal observations during pregnancy. J Infect Dis.\u20081978;137:524\u2013530","DOI":"10.1093\/infdis\/137.5.524"},{"key":"2021120819295198400_R34","doi-asserted-by":"crossref","unstructured":"Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ, Beachler CW. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies. Am J Obstet Gynecol.\u20081980;137:34\u201338","DOI":"10.1016\/0002-9378(80)90382-8"},{"key":"2021120819295198400_R35","doi-asserted-by":"crossref","unstructured":"Dillon HC Jr, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis.\u20081982;145:794\u2013799","DOI":"10.1093\/infdis\/145.6.794"},{"key":"2021120819295198400_R36","doi-asserted-by":"crossref","unstructured":"Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol.\u20081996;88:811\u2013815","DOI":"10.1016\/0029-7844(96)00320-1"},{"key":"2021120819295198400_R37","unstructured":"Morven S, Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn. 5th ed. Philadelphia, PA: WB Saunders Company; 2001:1099\u20131101"},{"key":"2021120819295198400_R38","doi-asserted-by":"crossref","unstructured":"Picard FJ, Bergeron MG. Laboratory detection of group B streptococcus for prevention of perinatal disease. Eur J Clin Microbiol Infect Dis.\u20082004;23:665\u2013671","DOI":"10.1007\/s10096-004-1183-8"},{"key":"2021120819295198400_R39","doi-asserted-by":"crossref","unstructured":"Bergeron MG, Ke D, Menard C, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med.\u20082000;343:175\u2013179","DOI":"10.1056\/NEJM200007203430303"},{"key":"2021120819295198400_R40","unstructured":"US Food and Drug Administration. FDA clears new lab test for group B Strep in pregnant women. FDA Talk Pap. Nov 18, 2002. Available at: www.fda.gov\/bbs\/topics\/ANSWERS\/2002\/ANS01172.HTML. Accessed August 26, 2004"},{"key":"2021120819295198400_R41","doi-asserted-by":"crossref","unstructured":"Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B streptococcus colonization in pregnant women. Clin Infect Dis.\u20082004;39:1129\u20131135","DOI":"10.1086\/424518"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/1240\/1029153\/zpe00505001240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/115\/5\/1240\/1029153\/zpe00505001240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T21:03:31Z","timestamp":1638997411000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/115\/5\/1240\/67627\/Early-Onset-Group-B-Streptococcal-Disease-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,5,1]]},"published-print":{"date-parts":[[2005,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2275","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]}}}